A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): Preliminary toxicity report

International Journal of Radiation Oncology Biology Physics

Volumn 37, Issue 3, 1997, Pages 593-599

  Gaspar, Laurie E ^a   Qian, Chunlin ^b   Kocha, Walter I ^c   Coia, Lawrence R ^d   Herskovic, Arnold ^e   Graham, Mary ^f  

^a WAYNE STATE UNIVERSITY   (United States)

^b RTOG Headquarters   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d FOX CHASE CANCER CENTER   (United States)

^e OAKWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brachytherapy; Esophagus cancer

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; ESOPHAGUS CANCER; ESOPHAGUS FISTULA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION SICKNESS; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL FISTULA; ESOPHAGEAL NEOPLASMS; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HUMANS; IRIDIUM RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, HIGH-ENERGY; TREATMENT FAILURE;

EID: 0030909013     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00591-3     Document Type: Article

References (18)

1. Al-Sarraf, M.; Pajak, T.; Herskovic, A.; Leichman, L.; Brindle, J. S.; Vaitkevicius, K.; Cooper, J.; Byhardt, R.; Davis, L.; Emami, B. Progress report of combined chemo-radiotherapy (CT-RT) versus radiotherapy (RT) alone in patients with esophageal cancer, an intergroup study. Proc. ASCO 12:197; 1993.
2. Barcat; Guisez, J. Essais de traitement de quelques cas d'epithelioma de l'oesophage par les applications locales directes de radium. Bull. Mem. Soc. Med. Hop. Paris 26:717-712; 1909.
3. Bottrill, D. O.; Plane, J. H.; Newaishy, G. A. A proposed afterloading technique for irradiation of the oesophagus. Br. J. Radiol. 52:573-574; 1979.
4. Dickson, R. J. Radiation therapy in carcinoma of the esophagus - A review. Am. J. Med. Sci. 241:662-677; 1971.
5. Flores, A. D.; Nelems, B.; Evans, K. G.; Evans, H; Evans, J. H.; Stoller, J. L.; Jackson, S. M. Impact of new radiotherapy modalities on the surgical management of cancer of the esophagus and cardia. Int. J. Radiat. Oncol. Biol. Phys. 17:937-944; 1989.
6. Guisez, J. Malignant tumors of the esophagus. J. Laryngol. Otol. 40:213-232; 1925.
7. Hareyama, M.; Nishio, M.; Kagami, Y.; Narimatsu, N.; Saito, A.; Sakurai, T. Intracavitary brachytherapy combined with external beam irradiation for squamous cell carcinoma of the thoracic esophagus. Int. J. Radiat. Oncol. Biol. Phys. 24:235-240; 1992.
8. Herskovic, A.; Martz, K.; Al-Sarraf, M.; Leichman, L.; Brindle, J.; Vaitkevicius, V.; Cooper, J.; Byhardt, R.; Davis, L.; Emami, B. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N. Engl. J. Med. 326:1593-1598; 1992.
9. Hishikawa, Y.; Kurisu, K.; Taniguchi, M.; Kamikonya, N.; Miura, T. High dose-rate intraluminal brachytherapy for esophageal cancer: 10 years experience in Hyogo College of Medicine. Radiother. Oncol. 21:107-114; 1991.
10. Hishikawa, Y.; Kurisu, K.; Taniguchi, M.; Kamikonya, N.; Miura, T. High-dose-rate intraluminal brachytherapy (HDRIBT) for esophageal cancer. Int. J. Radiat. Oncol. Biol. Phys. 21:1133-1135; 1991.
11. Hishikawa, Y.; Kamikonya, N.; Tanaka, S.; Miura, T. Radiotherapy of esophageal carcinoma: Role of high-dose-rate intracavitary irradiation. Radiother. Oncol. 9:13-20; 1987.
12. Hyden, E.C.; Langholz, B.; Tilden, T.; Lam, K.; Luxton, G.; Astrahan, M.; Jepson, J.; Petrovich, Z. External beam and intraluminal radiotherapy in the treatment of carcinoma of the esophagus. Thorac. Cardiovasc. Surg. 96:237-241; 1988.
13. Montravadi, R. V. P.; Gates, J. O.; Bajpai, D.; Crawford, J. N.; Trenkner, J. D.; Trenkner, D. A. Combined chemotherapy and external radiation therapy plus intraluminal boost with high dose rate brachytherapy for carcinoma of the esophagus. Endocurietherapy/Hyperthermia Oncol. 11:223-233; 1995.
14. Nori, D.; Allison, R. Prospects for improved treatment results with radiation dose escalation in esophageal cancer. Endocuriether/Hyperthermia Oncol. 9:63-67; 1993.
15. Staar, S.; Mueller, R. P.; Achterrath, W. Intensified treatment for inoperable esophagus cancer: simultaneous radiochemotherapy combined with HDR intraluminal brachytherapy: results of a phase II trial. Proc. ASCO (Abstr) 12:223; 1993.
16. Sur, R. K.; Kochhar, R.; Negi, P. S.; Gupta, B. D. High dose rate intraluminal brachytherapy in palliation of esophageal carcinoma. Endocuriether. Hyperthermia Oncol. 10:25-29; 1994.
17. Wang, R. Z.; Zhao, R. O. Combined intracavitary and external radiotherapy for esophageal carcinoma: a prospective randomized clinical trial on 128 patients. Chin. J. Radiat. Oncol. 1:41-43; 1987.
18. Yin, W. Brachytherapy of carcinoma of the esophagus in China, 1970-1974 and 1982-1984. Proc. Remote Afterloading. Brachytherapy Meeting. 34-35; 1989.